TCL Archive Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says. May 27, 2005
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center. December 7, 2001
TCL Archive Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium November 2, 1984
